It is, therefore, feasible to exploit IL-8 promoter to control the replication of oncolytic adenovirus aiming to achieve more tumor-targeted oncolysis for treating NSCLC.

• 因此，在非小细胞肺癌中以介白素八调控子控制溶瘤腺病毒应可具有更佳的肿瘤专一性与溶瘤效果。